Larson Financial Group’s Checkpoint Therapeutics CKPT Stock Holding History

Larson Financial Group’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$404	–	3320
2025 Q1	$404	Buy	+100	New	+$333	﹤0.01%	2629

Larson Financial Group's CKPT Position: Q2 2025 in Review

Larson Financial Group sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 100 shares — an estimated $404 sold.

Larson Financial Group first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $404 in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Larson Financial Group reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Larson Financial Group sold 100 Checkpoint Therapeutics shares in Q2 2025, an estimated $404.
Larson Financial Group first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Larson Financial Group's Checkpoint Therapeutics position peaked at $404 in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.